Skip to main content

Drug name(s)

Rusfertide Mimrylo™

Indications and usage

Rusfertide is a indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV).

Side effects needing medical attention

Most common adverse reactions were injection site reactions and anemia.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.